CLINICAL RESEARCH: LIPIDS AND VASCULAR DISEASE
Vascular Effects of Diet Supplementation With Plant Sterols
Oliver Weingärtner, MD*,
Dieter Lütjohann, PhD ,
Shengbo Ji||,
Nicole Weisshoff*,
Franka List*,
Thomas Sudhop, MD ,
Klaus von Bergmann, MD ,
Karen Gertz, MD||,
Jochem König, PhD¶,
Hans-Joachim Schäfers, MD ,
Matthias Endres, MD||,
Michael Böhm, MD* and
Ulrich Laufs, MD*,*
* Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany
Klinik für Thorax- und Herz-Gefäßchirurgie, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany
Institut für Klinische Chemie und Pharmakologie, Universitätsklinikum Bonn, Germany
Abteilung für Klinische Pharmakologie, Universitätsklinikum Bonn, Germany
|| Klinik und Poliklinik für Neurologie, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany
¶ Institut für Medizinische Biometrie, Epidemiologie und Informatik, Johannes Gutenberg-Universität Mainz, Germany.
Manuscript received June 22, 2007;
revised manuscript received August 29, 2007,
accepted September 10, 2007.
* Reprint requests and correspondence: Dr. Ulrich Laufs, Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, 66421 Homburg/Saar, Germany. (Email: ulrich{at}laufs.com).
Objectives: The purpose of this study was to evaluate vascular effects of diet supplementation with plant sterol esters (PSE).
Background: Plant sterol esters are used as food supplements to reduce cholesterol levels. Their effects on endothelial function, stroke, or atherogenesis are not known.
Methods: In mice, plasma sterol concentrations were correlated with endothelial function, cerebral lesion size, and atherosclerosis. Plasma and tissue sterol concentrations were measured by gas-liquid chromatography-mass spectrometry in 82 consecutive patients with aortic stenosis.
Results: Compared with those fed with normal chow (NC), wild-type mice fed with NC supplemented with 2% PSE showed increased plant sterol but equal cholesterol plasma concentrations. The PSE supplementation impaired endothelium-dependent vasorelaxation and increased cerebral lesion size after middle cerebral artery occlusion. To test the effects of cholesterol-lowering by PSE, apolipoprotein E (ApoE)–/– mice were randomized to Western-type diet (WTD) with the addition of PSE or ezetimibe (EZE). Compared with WTD, both interventions reduced plaque sizes; however, WTD + PSE showed larger plaques compared with WTD + EZE (20.4 ± 2.1% vs. 10.0 ± 1.5%). Plant sterol plasma concentration strongly correlated with increased atherosclerotic lesion formation (r = 0.50). Furthermore, we examined plasma and aortic valve concentrations of plant sterol in 82 consecutive patients with aortic stenosis. Patients eating PSE-supplemented margarine (n = 10) showed increased plasma concentrations and 5-fold higher sterol concentrations in aortic valve tissue.
Conclusions: Food supplementation with PSE impairs endothelial function, aggravates ischemic brain injury, effects atherogenesis in mice, and leads to increased tissue sterol concentrations in humans. Therefore, prospective studies are warranted that evaluate not only effects on cholesterol reduction, but also on clinical endpoints. (Concentration of Plant Sterols in Serum and Aortic Valve Cusps; NCT00222950)
|
Abbreviations and Acronyms
| | ApoE = apolipoprotein E | | EZE = ezetimibe | | LDLR = low-density lipoprotein receptor | | NC = normal chow | | PSE = plant sterol esters | | WTD = Western-type diet |
|
Related Articles
-
Vascular Effects of Diets, Especially Plant Sterol Ester Consumption
- Tatu A. Miettinen and Helena Gylling
J. Am. Coll. Cardiol. 2008 51: 1562-1563.
[Full Text]
[PDF]
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 51: A23-A24.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
V. Ramprasath, P. J. H. Jones, and J. Frohlich
Cholesterol-Lowering Foods and Reduction in Serum Cholesterol Levels--Reply
JAMA,
November 23, 2011;
306(20):
2218 - 2218.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Weingartner, M. Bohm, and U. Laufs
Cholesterol-Lowering Foods and Reduction in Serum Cholesterol Levels
JAMA,
November 23, 2011;
306(20):
2217 - 2218.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Thompson
Role of plant sterols in lipid lowering--a safety issue
QJM,
August 1, 2011;
104(8):
729 - 730.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Weingartner, C. Ulrich, D. Lutjohann, K. Ismail, S. H. Schirmer, T. Vanmierlo, M. Bohm, and U. Laufs
Differential effects on inhibition of cholesterol absorption by plant stanol and plant sterol esters in apoE-/- mice
Cardiovasc Res,
June 1, 2011;
90(3):
484 - 492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kreuzer
Phytosterols and phytostanols: is it time to rethink that supplemented margarine?
Cardiovasc Res,
June 1, 2011;
90(3):
397 - 398.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Silbernagel, G. Fauler, M. M. Hoffmann, D. Lutjohann, B. R. Winkelmann, B. O. Boehm, and W. Marz
The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality
J. Lipid Res.,
August 1, 2010;
51(8):
2384 - 2393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Teupser, R. Baber, U. Ceglarek, M. Scholz, T. Illig, C. Gieger, L. M. Holdt, A. Leichtle, K. H. Greiser, D. Huster, et al.
Genetic Regulation of Serum Phytosterol Levels and Risk of Coronary Artery Disease
Circ Cardiovasc Genet,
August 1, 2010;
3(4):
331 - 339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Rideout, S. V. Harding, D. Mackay, S. S. Abumweis, and P. J. Jones
High basal fractional cholesterol synthesis is associated with nonresponse of plasma LDL cholesterol to plant sterol therapy
Am J Clin Nutr,
July 1, 2010;
92(1):
41 - 46.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Derdemezis, T. D. Filippatos, D. P. Mikhailidis, and M. S. Elisaf
Review Article: Effects of Plant Sterols and Stanols Beyond Low-Density Lipoprotein Cholesterol Lowering
Journal of Cardiovascular Pharmacology and Therapeutics,
June 1, 2010;
15(2):
120 - 134.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Escurriol, M. Cofan, C. Moreno-Iribas, N. Larranaga, C. Martinez, C. Navarro, L. Rodriguez, C. A. Gonzalez, D. Corella, and E. Ros
Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort
J. Lipid Res.,
March 1, 2010;
51(3):
618 - 624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B Racette, X. Lin, M. Lefevre, C. A. Spearie, M. M Most, L. Ma, and R. E Ostlund Jr
Dose effects of dietary phytosterols on cholesterol metabolism: a controlled feeding study
Am J Clin Nutr,
January 1, 2010;
91(1):
32 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Weingartner, M. Bohm, and U. Laufs
Controversial role of plant sterol esters in the management of hypercholesterolaemia
Eur. Heart J.,
February 2, 2009;
30(4):
404 - 409.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Silbernagel, G. Fauler, W. Renner, E. M. Landl, M. M. Hoffmann, B. R. Winkelmann, B. O. Boehm, and W. Marz
The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease
J. Lipid Res.,
February 1, 2009;
50(2):
334 - 341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Miettinen and H. Gylling
Vascular Effects of Diets, Especially Plant Sterol Ester Consumption
J. Am. Coll. Cardiol.,
April 22, 2008;
51(16):
1562 - 1563.
[Full Text]
[PDF]
|
 |
|
|